Cellogen Therapeutics

Cellogen Therapeutics

HealthNoida, India

Cellogen Therapeutics is an Indian biotech startup that develops cell and gene therapies using Chimeric Antigen Receptor T-cell (CAR-T) technology to treat cancers and blood disorders. The company aims to make advanced therapies more accessible and affordable, addressing the high costs associated with existing CAR-T treatments.

$2.3MVisit website ↗

🏆 Featured in Datapile’s Q2 2026 India Funding Report

Read the Q2 2026 India report →
Add this badge to your site
Featured in Datapile’s Q2 2026 India Funding Report
<a href="https://datapile.co/reports/q2-2026-india-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 India Funding Report</a>

Funding history

  1. $2.3M2026-05-18
    Source: news.google.com ↗

Founder

Gaurav Kharya
Gaurav Kharya
Co-Founder

Investors in Cellogen Therapeutics

Backers from this company's tracked funding rounds.

  • Kotak Alternate Asset Managers

More Health companies

Recently funded startups in the same category.

Related on Datapile